Sun Pharmaceutical Industries Limited has announced that the audio recording of its investor call concerning the earnings for the third quarter of fiscal year 2026 (Q3 FY26) is now available on the company’s website. This recording provides insights into the company’s performance and management’s outlook.
Investor Call Audio Recording
Sun Pharma has released the audio recording of the investor call held to discuss the company’s earnings for the third quarter of fiscal year 2026 (Q3 FY26). The recording is accessible through the provided link:
https://sunpharma.com/wp-content/uploads/2026/01/FY26-Q3-Earnings-Call-Recording-10039711.mp3
This audio recording offers stakeholders the opportunity to review management’s discussion of the company’s financial results and strategic updates for the quarter ended December 31, 2025. This information was made available on January 31, 2026.
Source: BSE
